MULTIVESSEL VERSUS CULPRIT-ONLY PCI IN PATIENTS WITH NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION AND MULTIVESSEL DISEASE: RESULTS FROM THE PROMETHEUS STUDY

Authors :: Timothy Henry
Stuart Keller
Birgit Vogel
William S. Weintraub
Sandra Weiss
Jaya Chandrasekhar
Serdar Farhan
Stuart J. Pocock
Anthony C. DeFranco
Brian A. Baker
Samantha Sartori
Sunil V. Rao
Samir Kapadia
Catalin Toma
Sabato Sorrentino
Roxana Mehran
J. Muhlestein
Annapoorna Kini
Usman Baber
Craig Strauss
Michela Faggioni
Mark B. Effron
Source :: Journal of the American College of Cardiology. 69:1148
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.
Abstract: Background: Multivessel (MV) disease is present in a significant number of patients with non-ST-segment elevation myocardial infarction (NSTEMI). The optimal revascularization strategy in these patients is uncertain. Methods: PROMETHEUS was a multicenter observational study of patients undergoing

Subjects :: medicine.medical_specialty
business.industry
medicine.medical_treatment
Multivessel disease
medicine.disease
Revascularization
Culprit
Internal medicine
Conventional PCI
medicine
Cardiology
ST segment
Observational study
In patient
cardiovascular diseases
Myocardial infarction
Cardiology and Cardiovascular Medicine
business

Full Text Access

Tools